Fig 1: PDK1 expression was positively correlated with FTO A, B RT-qPCR (A) and western blot analysis (B) of PDK1 levels in in indicated MDA-MB-231 cells. C Western blot of FTO and PDK1 protein levels under 20 % or 1 % O2 in MDA-MB-231 cells for 24 h. D RT-qPCR of PDK1 expression levels exposed to 20 % or 1 % O2 for 12 h with or without HIF-1α Inhibitor 2-Methoxyestradiol (HY-12033, MedChemExpress) in MDA-MB-231 cells. E Western blot analysis of PDK1 protein levels in MDA-MB-231 cells with selective demethylase inhibitors of FTO FB23 (HY-137187, MedChemExpress) for 24 h. F, G Representative IHC staining images showing PDK1 expression in 25 normal breast tissues (low expression) and 78 breast cancer tissues (high expression) from HMUCH. Scale bar = 100 μm (low magnification) and 20 μm (high magnification). Sample percentage (in stacked column style) for each PDK1 score (G) from (F). 0 score means the lowest expression, 3 score means the highest expression. H Correlation analysis of the protein levels of FTO and PDK1 in breast cancer samples based on IHC analysis. I RT-qPCR analysis of PDK1 expression levels in 10 breast cancer tissues from HMUCH. J, Correlation between PDK1 and FTO mRNA levels in TCGA RNA-seq database. K, L Kaplan-Meier analysis of progression-free survival (K) or overall survival (L) of breast cancer patients in the TCGA database with high or low PDK1 expression. M Kaplan-Meier analysis of overall survival of breast cancer patients in the TCGA database with high or low FTO and high or low PDK1 expression. Data in (A, D and I) are presented as the means ± S.D. (n = 3). Student t-test, *, P < 0.05, **, P < 0.01, ***, P < 0.001. Data in (H) are analyzed by Pearson correlation test. Data in (J) are analyzed by Spearman’s Correlation Rank test. Data in (K, L and M) are analyzed by log-rank test.
Supplier Page from MedChemExpress for FB23